Bulk deals: Mobius Investment Trust offloads 0.52% stake in CarTrade Tech; Oaklane Capital Management picks up 0.79%

In bulk deals, Mateus Ltd bought 14 lakh shares (1.32 percent) of Bliss GVS Pharma at an average price of Rs 180.10, while Arian Investment was the seller.

• Sensex rose 78.56 points, Nifty up 48.45 points on February 5
• Oaklane Capital bought 3.8L Cartrade shares; Mobius sold 2.42L shares.
• Mateus Ltd acquired 14 lakh Bliss GVS Pharma shares in a block deal

Did our AI summary help?

The following bulk and block deals took place on both exchanges on February 5. At close, the Sensex was up 78.56 points or 0.09 percent at 83,817.69, and the Nifty was up 48.45 points or 0.19 percent at 25,776.

Bulk deals

CarTrade Tech saw Oaklane Capital Management LLP buy 3.80 lakh shares (0.79 percent stake) at an average price of Rs 2,232.93, while Mobius Investment Trust PLC sold 2.42 lakh shares (0.52 percent) at an average price of Rs 2,176.59. London-based Mobius Investment Trust is managed by Mobius Capital Partners and is led by Founding Partner Carlos Hardenberg. Last year, it was announced that veteran investor Mark Mobius who founded Mobius Capital Partners had decided to step away from his namesake investment firm.

Shares of Cartrade Tech fell nearly 3 percent on February 5 to close at Rs 2,311. The stock has fallen around 5 percent over the last five trading sessions.

In Prime Cable Industries, Aikyam Capital Management purchased 1.20 lakh shares (0.65 percent) at Rs 83 per share. The company is engaged in the manufacturing and sale of premium low-voltage, alongside control cables, aerial bunch cables, instrumentation cables, building wires, and conductors. At close, the stock was trading 0.58 percent higher at Rs 86.

SMC Global Securities saw Nishant Pitti buying 16.11 lakh shares (0.77 percent stake) at an average price of Rs 83.80. The stock of the online broking firm had been gaining over the last two days after reporting its Q3 numbers. For the quarter ended December 2025, consolidated net profit climbed 47.82 percent to Rs 30.54 crore compared to Q2 FY26. However, on a year-on-year basis, both the company’s net profit and revenue fell by 29.7%. At close on February 5, the stock was trading nearly 10 percent higher at Rs 85.9.

Victory Electric Vehicles International saw VBCube Ventures Fund II offload 2.13 lakh shares (0.88 percent stake) at Rs 21.50 each.

Block deals

Mateus Ltd bought 14 lakh shares (1.32 percent) of Bliss GVS Pharma at an average price of Rs 180.10, while Arian Investment was the seller. Bliss Pharma is a global manufacturer of suppositories and pessaries. At close, the stock was trading nearly 1 percent higher at Rs 186.